Archives

by in
Entry Author Date Location
Biotech & Pharma Whining About Talent: That Makes Me Mad 02/18/13 National
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
FDA Approves First Drug for Exelixis of South San Francisco 11/29/12 San Francisco
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Join Us Oct. 16 for ‘Reinventing Biotech’s Business Model’ in SF 09/11/12 San Francisco
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Join Risa Stack, Tony Coles & More for ‘Reinventing Biotech’ 08/09/12 San Francisco
OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug 08/02/12 Seattle
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show 05/14/12 National
OncoGenex Snags $50M for Prostate Cancer Drug Plan 03/16/12 Seattle
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up 03/08/12 Seattle
Bruce Booth, a LifeSciVC Shining Some Much-Needed Light on Biotech 02/27/12 National
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Exelixis To Push Ahead on Prostate Cancer Trial Without FDA Agreement: Shares Plunge 10/31/11 San Francisco
Exelixis Passes Key Test With Lead Drug; Stock Soars 10/24/11 San Francisco
What Most Biotechies Are Missing on Twitter: A Huge Networking Opportunity 09/12/11 National
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec 08/31/11 Boston
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials 07/18/11 San Diego
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Exelixis Zeroes in on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients 06/06/11 San Francisco
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All 06/06/11 National
FivePrime Nabs Partner, Solazyme’s $100M IPO Plan, Where Blockbuster Drugs Come From, & More Bay Area Life Sciences News 03/18/11 San Francisco
Exelixis Tacks on $23M 03/15/11 San Francisco
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.